(2,9-Dimethyl-1,10-phenanthroline-κ2 N,N′)bis­(2-hydroxy­benzoato)-κO;κ2 O,O′-cobalt(II)

In the title compound, [Co(C7H5O3)2(C14H12N2)], the CoII ion is five-coordinated by two N atoms from one 2,9-dimethyl-1,10-phenanthroline (dmphen) ligand and three O atoms from two 2-hydroxy­benzoate anions in a distorted trigonal bipyramidal geometry. The carboxyl­ate group of one of the two 2-hydroxy­benzoate anions is monodentate with a normal Co—O distance [1.9804 (18) Å], while the other is bidentate with two longer Co—O bonds [2.1981 (18) and 2.1359 (19) Å]. The crystal structure is stabilized by aromatic π–π stacking inter­actions [centroid–centroid distances of 4.0380 (3) and 3.8216 (3) Å between dmphen/dmphen and benzene/dmphen rings, respectively] and C—H⋯π(benzene) inter­actions

Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature

Only a few cases of extranodal Epstein-Barr virus (EBV)-associated B-cell lymphomas arising from patients with angioimmunoblastic T-cell lymphoma (AITL) have been described. We report a case of AITL of which secondary cutaneous EBV-associated diffuse large B-cell lymphoma (DLBCL) developed after the initial diagnosis of AITL. A 65-year-old Chinese male patient was diagnosed as AITL based on typical histological and immunohistochemical characteristics in biopsy of the enlarged right inguinal lymph nodes. The patient initially received 6 cycles of chemotherapy with CHOP regimen (cyclophosphamide, vincristine, adriamycin, prednisone), but his symptoms did not disappear. Nineteen months after initial diagnosis of AITL, the patient was hospitalized again because of multiple plaques and nodules on the skin. The skin biopsy was performed, but this time the tumor was composed of large, polymorphous population of lymphocytes with CD20 and CD79a positive on immunohistochemical staining. The tumor cells were strong positive for EBER by in situ hybridization. The findings of skin biopsy were compatible with EBV-associated DLBCL. CHOP-R chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab) was then administered, resulting in partial response of the disease with pancytopenia and suppression of cellular immunity. To our knowledge, this is the first case of cutaneous EBV-associated DLBCL originated from AITL in Chinese pepole. We suggest the patients with AITL should perform lymph node and skin biopsies regularly in the course of the disease to detect the progression of secondary lymphomas

Observation on health quality of life before and after the injection of antiangiogenic drug in vitreous cavity to patients with wet age-related macular degeneration

AbstractObjectiveTo explore the vision related health quality-of-life before and after the injection of antiangiogenic drug in vitreous cavity to patients with wet-AMD.MethodsThe 2000 edition of Visual Functioning Questionnaire-25 issued by National Eye Institute is applied, and the VRQL evaluation is conducted on the initial diagnosed patients with wet-AMD before and after the injection of ranibizumab drugs in vitreous cavity.ResultsAmong the wet-AMD patients, patients with better distance visual acuity before the intravitreal injection get lower VFQ-25 score; while after the vitreous cavity injection, the VFQ-25 questionnaire score is related to the explanation and nursing of doctors and nurses towards patients, the better the nursing, the higher the score.ConclusionBefore vitreous cavity injection, the degree of distance visual acuity is an important factor affecting VRQL of wet-AMD patients, in addition, the explanation and nursing of doctors and nurses toward patients during pre-operation, intra-operation and post-operation of intravitreal injection are also the import factors affecting VROL

Bis(benzoato-κ2 O,O′)(2,9-dimethyl-1,10-phenanthroline-κ2 N,N′)cobalt(II)

In the title compound, [Co(C7H5O2)2(C14H12N2)], the CoII ion is located on a twofold rotation axis and is chelated by a 2,9-dimethyl-1,10-phenanthroline (dmphen) ligand and two benzoate anions in a distorted octa­hedral geometry. The crystal packing is stabilized by π–π inter­actions between parallel dmphen ligands of neighbouring mol­ecules, with a face-to-face distance of 3.411 (2) Å

Beraprost Sodium, a Stable Analogue of PGI2, Inhibits the Renin-Angiotensin System in the Renal Tissues of Rats with Chronic Renal Failure

Background/Aims: Chronic renal failure (CRF) is a prolonged kidney condition characterized by decreased kidney function that can eventually develop into total kidney failure. The renin-angiotensin system (RAS) helps to regulate the balance between human bodily fluids and electrolytes. The aim of the present study was to investigate the effects of a prostacyclin analogue (beraprost sodium [BPS]) on the expression of key factors associated with local RAS activities in the renal tissues of rats with CRF. Methods: After a CRF rat model was successfully established, the levels of BUN, SCr, phosphorus, and calcium were detected by an automatic biochemistry analyzer. Furthermore, the activities of malondialdehyde (MDA) and superoxide dismutase (SOD) in rat renal tissues were measured using a colorimetric method, while the activity of angiotensin-converting enzyme (ACE) was determined by ultraviolet (UV) spectrophotometry. In situ hybridization was employed to determine the expression of angiotensin II type 1 receptor (AT). Finally, the positive expression rates of cells expressing important apoptotic proteins (Bax and Bcl-2) were determined, and the protein and mRNA levels of phosphatidylinositol 3-kinase (AKT) and key factors involved in the RAS (AT1, AT2, angiotensin ACE and angiotensinogen [AGT]) were evaluated by RT-qPCR and western blot analysis. Results: Initial observations revealed that treatment with BPS decreased the levels of BUN, SCr and phosphorus but increased calcium levels in the renal tissues of CRF rats. Additionally, BPS reduced the levels of MDA while increasing the levels of SOD, ACE activity, and AT1 expression in the renal tissues of CRF rats. BPS inhibited glomerular hypertension and hyperfiltration; increased the mRNA and protein levels of AKT and AT2; and decreased the mRNA and protein levels of AT1, AGT, and ACE in the renal tissues of CRF rats. Conclusion: The results of this study demonstrate that BPS, a PGI2 analogue, inhibits the expression of key factors involved in the local RAS, resulting in a delay in the occurrence and development of CRF. The key findings of the present study ultimately highlight the potential of this PGI2 analogue as a promising therapeutic strategy for treating CRF

Chinese Herbal Medicine for Myasthenia Gravis: A Systematic Review and Meta-Analysis

Myasthenia gravis (MG) is an acquired autoimmune disease with the disorder of the neuromuscular junction transmission caused by autoantibodies. Currently, various Chinese herbal medicines (CHMs) are widely used for MG. This meta-analysis was conducted to assess the effectiveness and safety of CHMs for MG and its possible mechanisms. Fourteen studies with 1039 individuals were identified by searching seven databases from inception to March 2017. The methodological quality was assessed by using 7-item criteria from the Cochrane’s Collaboration tool, and which assessed ≥4 “yes” in the domains were selected for detailed assessment and meta-analysis. All the data were analyzed using Rev-Man 5.3 software. Meta-analysis showed a significant effect of CHM as adjuvant therapy for improving the effectiveness compared with WCM alone or placebo in treating MG (p < 0.01). Moreover, there were fewer adverse effects and relapse rate in total when compared with the control group. The possible mechanisms of CHM for MG are associated with immunoregulation by reconstituting the functional ability of Tregs. In conclusion, despite the apparent positive results, the present evidence supports, to an extent, that CHM can be used for MG patients because of the methodological flaws and CHM heterogeneity. Further rigorous RCT for MG is needed